Revealed in a live announcement Marion Witz received the 33rd standing in the 9th annual PROFIT W100 ranking of Canada's Top Women Entrepreneurs by PROFIT Magazine: Your Guide to Business Success. This top ranking comes along with what has already proven to be a successful year for Witz, president of Elizabeth Grant Skincare.
Marion Witz re-launched Elizabeth Grant Skincare in 1997 in Toronto, ON. The company has experienced steady growth since its inception and now boasts a roster of 7 full time employees and 50 part time employees. Manufacturing and distributing luxury cosmetics, Elizabeth Grant Skincare is holding firm as a house hold name and a major player in the international beauty industry.
Ranking Canada's Top Women Entrepreneurs by the annual revenue of their firms, the Profit W100 profiles the country's most successful female business owners. Published in the November issue of PROFIT and online at PROFITguide.com, the PROFIT W100 is Canada's largest annual celebration of entrepreneurial achievement by women. "The PROFIT W100 are role models for entrepreneurs who lead companies of any size, in any sector" says Ian Portsmouth, editor of PROFIT. "Through effective management, they've built profitable, sustainable businesses."
Marion Witz has major plans for the continued growth of Elizabeth Grant Skincare. Having just launched several new products and new lines including the Vitamin C and Caviar line, which have become fast must-haves. Marion and her company are constantly Researching and Developing, in order to keep up with the ever-advancing skincare industry.
Marion Witz is well known for her exceptional contributions to charity and supports such causes as World Society for the Protection of Animals (WSPA), The Scarborough Hospital Foundation, and numerous other charities including large contributions to the Canadian Cancer Society. She also supports the community through product donations to local women's shelters.
Thursday, February 07, 2008
How Proud Are We? Ranked Number 33!
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment